These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7645559)

  • 1. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
    Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
    Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
    Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
    Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
    Pey R; Bach J; Schieren G; Gretz N; Hafner M
    In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
    Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease.
    Ramasubbu K; Gretz N; Bachmann S
    J Am Soc Nephrol; 1998 Jun; 9(6):937-45. PubMed ID: 9621276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents.
    Gattone VH; Cowley BD; Barash BD; Nagao S; Takahashi H; Yamaguchi T; Grantham JJ
    Am J Kidney Dis; 1995 Feb; 25(2):302-13. PubMed ID: 7847359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
    Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
    Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of disease progression in rats with inherited polycystic kidney disease.
    Cowley BD; Grantham JJ; Muessel MJ; Kraybill AL; Gattone VH
    Am J Kidney Dis; 1996 Jun; 27(6):865-79. PubMed ID: 8651252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.
    Aukema HM; Housini I
    Kidney Int; 2001 Jan; 59(1):52-61. PubMed ID: 11135057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
    Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
    Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.
    Torres VE; Bengal RJ; Nickander KK; Grande JP; Low PA
    Am J Kidney Dis; 1998 Apr; 31(4):687-93. PubMed ID: 9531187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-dependent effect of L-NAME on polycystic kidney disease in Han:SPRD rats.
    Yoshida I; Bengal R; Torres VE
    Am J Kidney Dis; 2000 May; 35(5):930-6. PubMed ID: 10793029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway.
    Jing Y; Wu M; Zhang D; Chen D; Yang M; Mei S; He L; Gu J; Qi N; Fu L; Li L; Mei C
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F479-F486. PubMed ID: 29513074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
    Cowley BD; Rupp JC; Muessel MJ; Gattone VH
    Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender.
    Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Aukema HM
    Lipids; 2006 Dec; 41(12):1141-9. PubMed ID: 17269560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats.
    Torres VE; Sweeney WE; Wang X; Qian Q; Harris PC; Frost P; Avner ED
    Kidney Int; 2003 Nov; 64(5):1573-9. PubMed ID: 14531789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease.
    Klawitter J; Zafar I; Klawitter J; Pennington AT; Klepacki J; Gitomer BY; Schrier RW; Christians U; Edelstein CL
    BMC Nephrol; 2013 Jul; 14():165. PubMed ID: 23902712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.